Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 3 of 4

Olav Mella (left), director of the oncology department at Haukeland University Hospital, Norway, and Øystein Fluge, a researcher and oncologist, from the same hospital, have conducted a 30-person randomised trial on chronic fatigue syndrome (CFS)

Olav Mella (left), director of the oncology department at Haukeland University Hospital, Norway, and Øystein Fluge, a researcher and oncologist, from the same hospital, are conducting a phase III trial of rituximab in chronic fatigue syndrome/myalgic encephalomyelitis patients

Source  Courtesy of Olav Mella and Øystein Fluge